药物对比
Semaglutide vs Troglitazone
Semaglutide（Ozempic/Wegovy）与已撤市Troglitazone治疗糖尿病的对比。现代GLP-1受体激动剂与2000年因致死性肝毒性撤市的TZD。比较现行选择。
此页面暂无可用的对比维度。
临床背景
Historical review of withdrawn diabetes drugs or patients asking about discontinued TZDs versus current GLP-1 therapies.
结论
Semaglutide is the appropriate modern choice; Troglitazone cannot be used because it was withdrawn for severe liver toxicity.
全部药物对比